DK1853581T3 - 2-Sulfinyl- og 2-sulfonyl-substituerede imidazolderivater og deres anvendelse som cytokininhibitorer - Google Patents
2-Sulfinyl- og 2-sulfonyl-substituerede imidazolderivater og deres anvendelse som cytokininhibitorerInfo
- Publication number
- DK1853581T3 DK1853581T3 DK06723133.2T DK06723133T DK1853581T3 DK 1853581 T3 DK1853581 T3 DK 1853581T3 DK 06723133 T DK06723133 T DK 06723133T DK 1853581 T3 DK1853581 T3 DK 1853581T3
- Authority
- DK
- Denmark
- Prior art keywords
- sulfinyl
- sulfonyl
- imidazole derivatives
- substituted imidazole
- cytokine inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- AIDS & HIV (AREA)
- Dermatology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65638905P | 2005-02-28 | 2005-02-28 | |
EP05004369 | 2005-02-28 | ||
PCT/EP2006/001801 WO2006089798A1 (en) | 2005-02-28 | 2006-02-27 | 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1853581T3 true DK1853581T3 (da) | 2010-09-27 |
Family
ID=34933989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06723133.2T DK1853581T3 (da) | 2005-02-28 | 2006-02-27 | 2-Sulfinyl- og 2-sulfonyl-substituerede imidazolderivater og deres anvendelse som cytokininhibitorer |
Country Status (20)
Country | Link |
---|---|
US (1) | US20100273833A1 (da) |
EP (1) | EP1853581B1 (da) |
JP (1) | JP2008531627A (da) |
KR (1) | KR20070107082A (da) |
CN (1) | CN101128453A (da) |
AT (1) | ATE469893T1 (da) |
AU (1) | AU2006218037B2 (da) |
BR (1) | BRPI0608739A2 (da) |
CA (1) | CA2599449A1 (da) |
DE (1) | DE602006014657D1 (da) |
DK (1) | DK1853581T3 (da) |
ES (1) | ES2351308T3 (da) |
IL (1) | IL184745A0 (da) |
MX (1) | MX2007010496A (da) |
NO (1) | NO20074912L (da) |
NZ (1) | NZ560264A (da) |
PT (1) | PT1853581E (da) |
RU (1) | RU2007135955A (da) |
WO (1) | WO2006089798A1 (da) |
ZA (1) | ZA200708203B (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1894925A1 (en) * | 2006-08-24 | 2008-03-05 | Merckle Gmbh | Imidazole compounds having an antiinflammatory effect |
US8143294B2 (en) | 2007-12-31 | 2012-03-27 | Michael Burnet | 2-sulfanyl-substituted imidazole derivatives and their use as cytokine inhibitors |
CN102249992A (zh) * | 2011-07-05 | 2011-11-23 | 广东工业大学 | 一种制备2-氨基异烟酸的方法 |
US20190060286A1 (en) | 2016-02-29 | 2019-02-28 | University Of Florida Research Foundation, Incorpo | Chemotherapeutic Methods |
CN114732910A (zh) | 2017-10-05 | 2022-07-12 | 弗尔康医疗公司 | P38激酶抑制剂降低dux4和下游基因表达以用于治疗fshd |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL133766A0 (en) * | 1997-06-30 | 2001-04-30 | Ortho Mcneil Pharm Inc | 2-substituted imidazoles useful in the treatment of inflammatory diseases |
GB9713726D0 (en) * | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
ATE323482T1 (de) * | 1999-07-02 | 2006-05-15 | Stuart A Lipton | Verwendung von p38 mapk inhibitoren in der behandlung von augenkrankheiten |
DE10107683A1 (de) * | 2001-02-19 | 2002-08-29 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
DE10114775A1 (de) * | 2001-03-26 | 2002-10-10 | Gerhard Dannhardt | 2-Mercapto-4,5-diarylimidazolderivate und ihre Verwendung in der Pharmazie |
KR20020009532A (ko) * | 2001-11-13 | 2002-02-01 | (주)쎌믹스 | 류코트리엔 합성 억제용 조성물 |
DE10222103A1 (de) * | 2002-05-17 | 2003-11-27 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
DE10238045A1 (de) * | 2002-08-20 | 2004-03-04 | Merckle Gmbh Chem.-Pharm. Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
-
2006
- 2006-02-27 PT PT06723133T patent/PT1853581E/pt unknown
- 2006-02-27 RU RU2007135955/04A patent/RU2007135955A/ru not_active Application Discontinuation
- 2006-02-27 ES ES06723133T patent/ES2351308T3/es active Active
- 2006-02-27 CN CNA2006800062247A patent/CN101128453A/zh active Pending
- 2006-02-27 BR BRPI0608739-6A patent/BRPI0608739A2/pt not_active IP Right Cessation
- 2006-02-27 EP EP06723133A patent/EP1853581B1/en active Active
- 2006-02-27 AT AT06723133T patent/ATE469893T1/de not_active IP Right Cessation
- 2006-02-27 MX MX2007010496A patent/MX2007010496A/es not_active Application Discontinuation
- 2006-02-27 DE DE602006014657T patent/DE602006014657D1/de active Active
- 2006-02-27 JP JP2007557404A patent/JP2008531627A/ja active Pending
- 2006-02-27 NZ NZ560264A patent/NZ560264A/en not_active IP Right Cessation
- 2006-02-27 WO PCT/EP2006/001801 patent/WO2006089798A1/en active Application Filing
- 2006-02-27 US US11/817,298 patent/US20100273833A1/en not_active Abandoned
- 2006-02-27 DK DK06723133.2T patent/DK1853581T3/da active
- 2006-02-27 CA CA002599449A patent/CA2599449A1/en not_active Abandoned
- 2006-02-27 AU AU2006218037A patent/AU2006218037B2/en not_active Ceased
- 2006-02-27 KR KR1020077019748A patent/KR20070107082A/ko not_active Application Discontinuation
-
2007
- 2007-07-19 IL IL184745A patent/IL184745A0/en unknown
- 2007-09-26 ZA ZA200708203A patent/ZA200708203B/xx unknown
- 2007-09-27 NO NO20074912A patent/NO20074912L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2006089798A1 (en) | 2006-08-31 |
DE602006014657D1 (de) | 2010-07-15 |
BRPI0608739A2 (pt) | 2011-03-15 |
AU2006218037A1 (en) | 2006-08-31 |
ZA200708203B (en) | 2008-10-29 |
CN101128453A (zh) | 2008-02-20 |
IL184745A0 (en) | 2007-12-03 |
US20100273833A1 (en) | 2010-10-28 |
NZ560264A (en) | 2009-11-27 |
NO20074912L (no) | 2007-11-28 |
AU2006218037B2 (en) | 2012-04-05 |
ATE469893T1 (de) | 2010-06-15 |
JP2008531627A (ja) | 2008-08-14 |
ES2351308T3 (es) | 2011-02-02 |
CA2599449A1 (en) | 2006-08-31 |
EP1853581B1 (en) | 2010-06-02 |
KR20070107082A (ko) | 2007-11-06 |
EP1853581A1 (en) | 2007-11-14 |
PT1853581E (pt) | 2010-09-09 |
RU2007135955A (ru) | 2009-04-10 |
MX2007010496A (es) | 2007-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL301145I2 (nl) | Tirbanibulin | |
DK1483265T3 (da) | Purinderivater som kinaseinhibitorer | |
NO20063925L (no) | Indazolderivater som inhibitorer av hormonsensitiv lipase | |
NO20083427L (no) | Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse | |
EA200801428A1 (ru) | Производные пиридиазинона для лечения опухолей | |
NO20083726L (no) | Spiroindolinon derivater | |
MA32544B1 (fr) | Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique | |
EA200501928A1 (ru) | Пирролодигидроизохинолины как ингибиторы pde10 | |
CY1113314T1 (el) | (3-αρυλ-πιπεραζιν-1-υλ) παραγωγα της 6,7-διαλκοξυκιναζολινης, 6,7-διαλκοξυφθαλαζινης και 6,7-διαλκοξυϊσοκινολινης | |
NO20064976L (no) | Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser | |
NO20062020L (no) | 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika | |
MX2008001538A (es) | Aril piridinas y metodos para su uso. | |
NO20081454L (no) | Met-kinaseinhibitorer | |
NO20082026L (no) | Deazapuriner som er nyttige som inhibitorer for Janus-kinaser | |
ATE517896T1 (de) | P38-kinase-inhibitoren | |
NO20083501L (no) | Azaindoler som er anvendelige som inhibitorer for Janus-kinaser | |
NO20054848L (no) | Substituerte p-diaminobenzenderivater | |
NO20083923L (no) | Pyrazolkinoloner er potente parp-inhibitorer | |
ATE553093T1 (de) | Indazolderivate zur hemmung von trpv1 und verwendungen davon | |
NO20081942L (no) | Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser | |
MY147649A (en) | Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders | |
ATE484501T1 (de) | Als protein-kinase-inhibitoren nutzbare benzimidazole | |
NO20055563L (no) | Midler for behandlingen av lavere abdominale lidelser | |
MX2010005047A (es) | Inhibidores de aldh-2 en el tratamiento de enfermedades psiquiatricas. | |
DK1853581T3 (da) | 2-Sulfinyl- og 2-sulfonyl-substituerede imidazolderivater og deres anvendelse som cytokininhibitorer |